Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LIFE

aTyr Pharma (LIFE) Stock Price, News & Analysis

aTyr Pharma logo

About aTyr Pharma Stock (NASDAQ:LIFE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.57
$2.07
52-Week Range
N/A
Volume
269,400 shs
Average Volume
514,103 shs
Market Capitalization
$131.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LIFE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for aTyr Pharma and its competitors with MarketBeat's FREE daily newsletter.

LIFE Stock News Headlines

aTyr: Promising Data, But Cash May Be An Issue
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Is aTyr Pharma (ATYR) The Hot Biotech Stock Under $5?
aTyr Pharma (ATYR) Receives a Buy from Wells Fargo
aTyr Pharma director buys $15K in common stock
See More Headlines

LIFE Stock Analysis - Frequently Asked Questions

aTyr Pharma, Inc. (NASDAQ:LIFE) posted its quarterly earnings data on Thursday, May, 2nd. The biotechnology company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.01. The biotechnology company had revenue of $0.24 million for the quarter, compared to analyst estimates of $0.11 million.

aTyr Pharma shares reverse split before market open on Monday, July 1st 2019.The 1-14 reverse split was announced on Friday, June 28th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 28th 2019. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

aTyr Pharma (LIFE) raised $76 million in an initial public offering (IPO) on Thursday, May 7th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Citigroup acted as the underwriters for the IPO and BMO Capital Markets and William Blair were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that aTyr Pharma investors own include Tesla (TSLA), Plug Power (PLUG), Meta Platforms (META), NVIDIA (NVDA), SCYNEXIS (SCYX), Ford Motor (F) and NIO (NIO).

Company Calendar

Last Earnings
5/02/2024
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:LIFE
Employees
56
Year Founded
2005

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.39 million
Pretax Margin
-9,172.11%

Debt

Sales & Book Value

Annual Sales
$350 thousand
Price / Cash Flow
N/A
Book Value
$1.54 per share
Price / Book
N/A

Miscellaneous

Free Float
66,458,000
Market Cap
$131.12 million
Optionable
Optionable
Beta
1.19

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:LIFE) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners